Avagliano Mark
Chief Business Officer at G1 Therapeutics, Inc.
- Sold, on record
- $74k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jul 5, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- G1 Therapeutics, Inc.Chief Business Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 5, 2022 2022
Sold 1,445 shares at $10.61 ($15k)
Avagliano Mark, Chief Business Officer
Sold 6.3% of holdings ($244k position)21,555 shares leftFirst sale on recordFiling
- 2 Form 4 sale G1 Therapeutics, Inc.No planJan 4, 2024 +729 days
Sold 4,081 shares at $3.09 ($13k)
Avagliano Mark, Chief Business Officer
No 10b5-1 planSold 3.3% of holdings ($376k position)117,834 shares leftFiling
- 3 Form 4 sale G1 Therapeutics, Inc.No planMay 13, 2024 +130 days
Sold 8,151 shares at $4.79 ($39k)
Avagliano Mark, Chief Business Officer
No 10b5-1 planSold 3.7% of holdings ($1M position)209,683 shares leftFiling
- 4 Form 4 sale G1 Therapeutics, Inc.No planJul 5, 2024 +53 days
Sold 2,638 shares at $2.51 ($7k)
Avagliano Mark, Chief Business Officer
No 10b5-1 planSold 1.1% of holdings ($614k position)242,045 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | Jul 8, 2024 | G1 Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 2,638 | $7k | 1.1% | No plan | SEC |
| May 13, 2024 | May 15, 2024 | G1 Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 8,151 | $39k | 3.7% | No plan | SEC |
| Jan 4, 2024 | Jan 8, 2024 | G1 Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 4,081 | $13k | 3.3% | No plan | SEC |
| Jan 5, 2022 | Jan 5, 2022 | G1 Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 1,445 | $15k | 6.3% | Plan not stated | SEC |